acebutolol has been researched along with Meningitis, Meningococcal, Serogroup A in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bainbridge, P; Griffith, JM; Hogan, TR; Neill, R; Tapsall, JW; Tribe, D; Zaia, A | 1 |
| Granato, PA; Howard, R; Laser, J; Wilkinson, B | 1 |
| Casal, J; Fenoll, A; Sáez-Nieto, JA; Vazquez, J | 1 |
| Bisquert, J; Dominguez, J; Lopez-Alonso, JA; Saez-Nieto, JA | 1 |
4 other study(ies) available for acebutolol and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
Molecular tests can allow confirmation of invasive meningococcal disease when isolates yield atypical maltose, glucose or gamma-glutamyl peptidase test results.
Topics: DNA, Bacterial; gamma-Glutamyltransferase; Glucose; Humans; Immunoglobulin Variable Region; Maltose; Meningitis, Meningococcal; Neisseria meningitidis; Polymerase Chain Reaction; Porins; Serotyping | 2005 |
Meningitis caused by maltose-negative variant of Neisseria meningitidis.
Topics: Adult; Blood; Carrier State; Cerebrospinal Fluid; Fathers; Genetic Variation; Humans; Infant; Male; Maltose; Meningitis, Meningococcal; Nasopharynx; Neisseria meningitidis; Pharynx | 1980 |
Prevalence of maltose-negative Neisseria meningitidis variants during an epidemic period in Spain.
Topics: Disease Outbreaks; Humans; Maltose; Meningitis, Meningococcal; Neisseria meningitidis; Serotyping; Spain | 1982 |
Meningitis due to a glucose-negative, maltose-negative strain of Neisseria meningitidis.
Topics: Child, Preschool; Glucose; Humans; Male; Maltose; Meningitis, Meningococcal; Neisseria meningitidis | 1986 |